Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Hydromorphone has a clear analgesic effect, and has few advantages in respiratory depression
and gastrointestinal motility. The study will further explore the continuous pumping-dose of
hydromorphone for ICU non-mechanical ventilation patients and monitor its effective plasma
concentration as well as evaluates the safety and effectiveness of hydromorphone for ICU
non-mechanical ventilation patients.